4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0001209191-22-011470
Options or other derivatives
- PRESIDENT AND CEO acquired 650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2022-02-16 | Grant or award · Stock Option (right to buy) | +650,000 | 650,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…